A new discovery by researchers at the University of New South Wales could revolutionize the way drugs are delivered to treat brain disorders. The team has created a new thyroxine derivative which can act as a “carrier molecule” to deliver drugs to the brain more efficiently. This new derivative is a modified form of the naturally occurring hormone thyroxine, and it has the potential to transport drugs directly into the brain without crossing the blood-brain barrier. This could mean that medications can be administered in much lower doses, reducing the risk of side effects and providing a more effective treatment for neurological disorders. The team is now working to further develop this thyroxine derivative for clinical use.

Read Full Article Here

source: Phys.org